Gsa Capital Partners LLP Dyne Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$4.36 - $10.5 $52,088 - $125,443	-11,947 Reduced 42.75%	15,996 $110,000
Q1 2022 May 11, 2022	BUY	$6.52 - $12.27 $30,969 - $58,282	4,750 Added 20.48%	27,943 $269,000
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $51,804 - $70,016	4,357 Added 23.13%	23,193 $276,000
Q3 2021 Nov 12, 2021	BUY	$15.6 - $21.46 $293,841 - $404,220	18,836 New	18,836 $306,000

209

102M

234K

238K

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.24B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.